Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers from Genomill Health Inc., the University of Turku, and the TYKS Turku University Hospital, Finland, benchmarked this new method, Bridge Capture, against two market-leading tools.

Five warning signs of diabetes

Diabetes is a lifelong disease that affects almost 12% of people in the United States, according to the Centers for Disease Control and Prevention (CDC). Many of these people are often undiagnosed, too, putting them at risk of complications.